These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 8043236)
21. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia. Falloon J; Lavelle J; Ogata-Arakaki D; Byrne A; Graziani A; Morgan A; Amantea MA; Ownby K; Polis M; Davey RT Antimicrob Agents Chemother; 1994 Jul; 38(7):1580-7. PubMed ID: 7979291 [TBL] [Abstract][Full Text] [Related]
22. Comparative efficacy and safety of Pneumocystis jirovecii pneumonia prophylaxis regimens for people living with HIV: a systematic review and network meta-analysis of randomized controlled trials. Prosty C; Katergi K; Sorin M; Rjeily MB; Butler-Laporte G; McDonald EG; Lee TC Clin Microbiol Infect; 2024 Jul; 30(7):866-876. PubMed ID: 38583518 [TBL] [Abstract][Full Text] [Related]
23. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371 [TBL] [Abstract][Full Text] [Related]
24. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS. Payen MC; De Wit S; Sommereijns B; Clumeck N Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502 [TBL] [Abstract][Full Text] [Related]
28. Dilemmas in the prophylaxis of Pneumocystis carinii pneumonia. Glatt AE South Med J; 1994 Apr; 87(4):429-30. PubMed ID: 8153765 [TBL] [Abstract][Full Text] [Related]
29. Administration of pyrimethamine/sulfadoxine for prevention of Pneumocystis carinii pneumonia in patients with AIDS. Bessesen MT; Miller LA; Cohn DL; Bartlett S; Ellison RT Clin Infect Dis; 1995 Mar; 20(3):730-1. PubMed ID: 7756514 [No Abstract] [Full Text] [Related]
30. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994]. Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164 [TBL] [Abstract][Full Text] [Related]
31. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747 [TBL] [Abstract][Full Text] [Related]
32. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Opravil M; Joos B; Lüthy R Antimicrob Agents Chemother; 1994 May; 38(5):1197-9. PubMed ID: 8067765 [TBL] [Abstract][Full Text] [Related]
33. [Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and Toxoplasma encephalitis]. Teira R; Virosta M; Baraia-Etxaburu J; Muñoz J; Zubero Z; Cisterna R; Santamaría JM Enferm Infecc Microbiol Clin; 1999; 17(7):347-9. PubMed ID: 10535188 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Ruf B; Schürmann D; Bergmann F; Schüler-Maué W; Grünewald T; Gottschalk HJ; Witt H; Pohle HD Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):325-9. PubMed ID: 8354297 [TBL] [Abstract][Full Text] [Related]
35. Prevention of Pneumocystis carinii pneumonia. Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408 [No Abstract] [Full Text] [Related]
36. Dapsone/pyrimethamine versus aerosolized pentamidine as prophylaxis against PCP in HIV infection. Dorrell L; McCallum AK; Snow MH; Ong EL AIDS Patient Care; 1995 Oct; 9(5):224-8. PubMed ID: 11361401 [No Abstract] [Full Text] [Related]